This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1fxy

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1fxy.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1fxy.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1fxy| PDB=1fxy | SCENE= }}
{{STRUCTURE_1fxy| PDB=1fxy | SCENE= }}
-
'''COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG-CHLOROMETHYLKETONE'''
+
===COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG-CHLOROMETHYLKETONE===
-
==Overview==
+
<!--
-
Protein functions have evolved in part via domain recombination events. Such events, for example, recombine structurally independent functional domains and shuffle targeting, regulatory, and/or catalytic functions. Domain recombination, however, can generate new functions, as implied by the observation of catalytic sites at interfaces of distinct folding domains. If useful to an evolving organism, such initially rudimentary functions would likely acquire greater efficiency and diversity, whereas the initially distinct folding domains would likely develop into single functional domains. This represents the probable evolution of the S1 serine protease family, whose two homologous beta-barrel subdomains assemble to form the binding sites and the catalytic machinery. Among S1 family members, the contact interface and catalytic residues are highly conserved whereas surrounding surfaces are highly variable. This observation suggests a new strategy to engineer viable proteins with novel properties, by swapping folding subdomains chosen from among protein family members. Such hybrid proteins would retain properties conserved throughout the family, including folding stability as single domain proteins, while providing new surfaces amenable to directed evolution or engineering of specific new properties. We show here that recombining the N-terminal subdomain from coagulation factor X with the C-terminal subdomain from trypsin creates a potent enzyme (fXYa) with novel properties, in particular a broad substrate specificity. As shown by the 2.15-A crystal structure, plasticity at the hydrophobic subdomain interface maintains activity, while surface loops are displaced compared with the parent subdomains. fXYa thus represents a new serine proteinase lineage with hybrid fX, trypsin, and novel properties.
+
The line below this paragraph, {{ABSTRACT_PUBMED_9707558}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 9707558 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_9707558}}
==About this Structure==
==About this Structure==
Line 32: Line 36:
[[Category: Protease]]
[[Category: Protease]]
[[Category: Trypsin]]
[[Category: Trypsin]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 16:53:25 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 1 04:06:34 2008''

Revision as of 01:06, 1 July 2008

Image:1fxy.png

Template:STRUCTURE 1fxy

COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG-CHLOROMETHYLKETONE

Template:ABSTRACT PUBMED 9707558

About this Structure

Full crystallographic information is available from OCA.

Reference

New enzyme lineages by subdomain shuffling., Hopfner KP, Kopetzki E, Kresse GB, Bode W, Huber R, Engh RA, Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):9813-8. PMID:9707558

Page seeded by OCA on Tue Jul 1 04:06:34 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1fxy"
Personal tools